One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since its founding in 1981, the company has introduced breakthrough treatments across several areas of medicine that have provided new hope for patients. Today, approximately 10,000 Genzyme employees serve patients in nearly 100 countries.

Genzyme?s products are focused on rare genetic diseases, multiple sclerosis, cardiovascular disease, and endocrinology. The company?s commitment to innovation continues today with a substantial development program focused on these fields, as well as other areas of unmet medical need. Genzyme is a Sanofi company.

At Genzyme they are mindful of their responsibility to all of their stakeholders, including patients, physicians, shareholders, employees and our communities. They are driven, first and always, by their commitment to patients. Genzyme exists to innovate on behalf of people with serious diseases and to meet major unmet medical needs. This commitment includes all patients, regardless of their location or financial circumstances. Genzyme has a strong presence in developing countries, where they work with physicians and governments to build sustainable health care systems and provide free medicine to patients in countries where those systems do not yet exist.